Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Market watch

Forecasting market share in the US pharmaceutical market

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1: Forecasting the market share of drugs in the US market.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Stephane A. Regnier or David B. Ridley.

Ethics declarations

Competing interests

Stephane A. Régnier is an employee of Novartis Pharma AG. The views in the article are those of the authors, not necessarily those of Novartis Pharma AG.

Related links

FURTHER INFORMATION

Haute Autorité de Santé

PowerPoint slides

Supplementary information

Supplementary information S1 (Box)

Data and analysis methods (PDF 1456 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Regnier, S., Ridley, D. Forecasting market share in the US pharmaceutical market. Nat Rev Drug Discov 14, 594–595 (2015). https://doi.org/10.1038/nrd4697

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd4697

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing